Letter to the Editor
Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adult
T. Prarthana,
T. Prarthana
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author S. Bakshi,
S. Bakshi
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author V. Hanumanthu,
V. Hanumanthu
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author U. Nahar,
U. Nahar
Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author D. De,
Corresponding Author
D. De
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
*Correspondence: D. De. E-mail: [email protected]
Search for more papers by this author
T. Prarthana,
T. Prarthana
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author S. Bakshi,
S. Bakshi
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author V. Hanumanthu,
V. Hanumanthu
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author U. Nahar,
U. Nahar
Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Search for more papers by this author D. De,
Corresponding Author
D. De
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
*Correspondence: D. De. E-mail: [email protected]
Search for more papers by this author
First published: 08 February 2022
No abstract is available for this article.
Data Availability Statement
Not applicable.
References
- 1Canelas MM, Coelho S, Reis J, Moreno A, Tellechea I, Figueiredo A. Eruptive pseudoangiomatosis. Eur J Dermatol 2009; 19: 77–78.
- 2Cherry JD, Bobinski JE, Horvath FL, Comerci GD. Acute hemangioma-like lesions associated with ECHO viral infections. Pediatrics 1969; 44: 498–502.
- 3Navarro V, Molina I, Montesinos E, Calduch L, Jorda E. Eruptive pseudoangiomatosis in an adult. Int J Dermatol 2000; 39: 237–238.
- 4Gonzalez Saldana S, Mendez Flores RG, Lopez Gutierrez AF et al. Eruptive pseudoangiomatosis in adults with immune system disorders: a report of two cases. Dermatol Reports 2020; 12: 8836.
- 5Gresham LM, Marzario B, Dutz J, Kirchhof MG. An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology. J Am Acad Dermatol 2021; 84: 1652–1666.
- 6Robinson LB, Fu X, Hashimoto D et al. Incidence of cutaneous reactions after messenger RNA COVID-19 vaccines. JAMA Dermatol 2021; 157: 1000–1002.
- 7Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021. JAMA 2021; 325: 1101–1102.
- 8Alonzo Caldarelli A, Barba P, Hurtado M. Eruptive pseudoangiomatosis and SARS-CoV-2 (COVID-19) infection. Int J Dermatol 2021; 60: 1028–1029.
